The poly(ADP-ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy

Medicine and Dentistry

• Epidermal Growth Factor Receptor 100%
• Head and Neck Cancer 100%
• PARP Inhibitor 100%
• Head and Neck Tumor 100%
• Radiation Therapy 100%
• Poly ADP Ribose Polymerase 50%
• Poly(adenosine Diphosphate Ribose) 50%
• DNA Damage 33%
• Cancer Cell 33%
• Non-Homologous End Joining 33%
• Immunohistochemistry 33%
• Quality of Life 16%
• Neoplasm 16%
• Biological Marker 16%
• Cancer Susceptibility 16%
• Colony Formation 16%
• DNA Ligase 16%
• Comet Assay 16%
• Cytotoxicity 16%
• Immunoblotting 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor 100%
• Head and Neck Tumor 100%
• Head and Neck Cancer 100%
• Epidermal Growth Factor Receptor 100%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 50%
• Poly(adenosine Diphosphate Ribose) 50%
• Western Blot 16%
• Biological Marker 16%
• Cancer Susceptibility 16%
• Comet Assay 16%
• Neoplasm 16%
• DNA Ligase 16%
• Cytotoxicity 16%